Malignant Peripheral Nervous System Neoplasm

Malignant Peripheral Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

60 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20
Recruiting: 13
Ph III recruiting: 0
Growth YoY: —
Industry share: 20%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 51–60 of 60 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00931931	HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors	completed	Phase 1	18	Timothy CripeOTHER	1	Mar 21, 2018	clinicaltrials
NCT01418001	Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)	terminated	Phase 1 / Phase 2	5	Memorial Sloan Kettering Cancer CenterOTHER	1	Jan 11, 2018	clinicaltrials